In investigative journalism, many newsrooms have begun implementing an “impact strategy.” How can they do better and what is ...
(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA ® (talazoparib), an oral poly ...